These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 624699)
41. Suppurative thyroiditis with gas formation due to mixed anaerobic infection. Bussman YC; Wong ML; Bell MJ; Santiago JV J Pediatr; 1977 Feb; 90(2):321-2. PubMed ID: 830929 [No Abstract] [Full Text] [Related]
42. Bacteraemia due to a rifampicin-resistant strain of Bacteroides fragilis. Bullock DW; Webb AJ; Duerden BI; Rotimi VO J Clin Pathol; 1981 Jan; 34(1):87-9. PubMed ID: 7462441 [TBL] [Abstract][Full Text] [Related]
43. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390 [TBL] [Abstract][Full Text] [Related]
44. Antibiotic susceptibility profiles of European Bacteroides fragilis with reduced carbapenem susceptibility. Hawser SP; Hackel M; Hoban DJ J Antimicrob Chemother; 2010 Apr; 65(4):803-4. PubMed ID: 20130025 [No Abstract] [Full Text] [Related]
45. Bacteroides fragilis: a case study of bacteremia and septic arthritis. Martin T; Aziz H Clin Lab Sci; 2009; 22(3):131-5. PubMed ID: 19827405 [TBL] [Abstract][Full Text] [Related]
46. Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains. Katsandri A; Papaparaskevas J; Pantazatou A; Petrikkos GL; Thomopoulos G; Houhoula DP; Avlamis A J Clin Microbiol; 2006 Sep; 44(9):3465-7. PubMed ID: 16954304 [TBL] [Abstract][Full Text] [Related]
47. The clinical significance of clindamycin-resistant Bacteroides fragilis. Yee MH; Guiney DG; Hasegawa P; Davis CE JAMA; 1982 Oct; 248(15):1860-1. PubMed ID: 7120605 [TBL] [Abstract][Full Text] [Related]
48. Molecular and ecological aspects of antibiotic resistance in the Bacteroides fragilis group. Martínez-Suárez JV; Baquero F Microbiologia; 1987 Oct; 3(3):149-62. PubMed ID: 3077327 [TBL] [Abstract][Full Text] [Related]
49. High rates of reduced susceptibility in the Bacteroides fragilis group isolated from blood cultures--the first national survey in Denmark. Justesen US; Hansen F; Østergaard C; Schønheyder HC; Hansen DS; Lemming LE; Schumacher H; Heltberg O; Knudsen JD; Dzajic E; Arpi M; Hammerum AM Int J Antimicrob Agents; 2013 Aug; 42(2):188-90. PubMed ID: 23773329 [No Abstract] [Full Text] [Related]
50. The first characterized carbapenem-resistant Bacteroides fragilis strain from Croatia and the case study for it. Bogdan M; Perić L; Ördög K; Vuković D; Urbán E; Sóki J Acta Microbiol Immunol Hung; 2018 Aug; 65(3):317-323. PubMed ID: 29651861 [TBL] [Abstract][Full Text] [Related]
51. [In vitro evaluation of the activity and interactions of cefotaxime and its metabolite desacetylcefotaxime against strains of enterobacteria, staphylococci and Bacteroides fragilis isolated from hospital infections]. Pitzus E G Ital Chemioter; 1989; 36(1-3):57-64. PubMed ID: 2488914 [TBL] [Abstract][Full Text] [Related]
52. [Evolution of the sensitivity of Bacteroides group fragilis at the Sevilla University Hospital (1983-1987)]. Borobio MV; Domínguez MC; Pallares JA; Perea EJ Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):214-8. PubMed ID: 1863620 [TBL] [Abstract][Full Text] [Related]
53. Cerebral Abscess caused by Novel Species: Streptococcus Pluranimalium. Ahmed A; Zaman G; Gardezi A; Satti L; Sabir N; Haleem A J Coll Physicians Surg Pak; 2018 Sep; 28(9):S181-S183. PubMed ID: 30173691 [TBL] [Abstract][Full Text] [Related]
54. Group G Streptococci in association with brain abscess: a rare occurrence. Subramani P; Raja V; Lingaiah BB; Madappa BP; Chakravarthy H J Infect Dev Ctries; 2014 Nov; 8(11):1488-90. PubMed ID: 25390063 [TBL] [Abstract][Full Text] [Related]
55. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility]. Rodríguez E; Gamboa MM; Rodríguez C; Vargas P Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405 [TBL] [Abstract][Full Text] [Related]
56. Antimicrobial susceptibility testing of Bacteroides fragilis using the MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA). Justesen US; Acar Z; Sydenham TV; Johansson Å; Anaerobe; 2018 Dec; 54():236-239. PubMed ID: 29501419 [TBL] [Abstract][Full Text] [Related]
57. Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infection. Stearne LE; Goessens WH; Mouton JW; Gyssens IC Antimicrob Agents Chemother; 2007 Oct; 51(10):3605-11. PubMed ID: 17646416 [TBL] [Abstract][Full Text] [Related]
58. Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington State. Schapiro JM; Gupta R; Stefansson E; Fang FC; Limaye AP J Clin Microbiol; 2004 Sep; 42(9):4127-9. PubMed ID: 15364999 [TBL] [Abstract][Full Text] [Related]
59. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea. Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890 [TBL] [Abstract][Full Text] [Related]
60. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital. Yim J; Lee Y; Kim M; Seo YH; Kim WH; Yong D; Jeong SH; Lee K; Chong Y Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]